Nasal Spray Is A New Antidepressant Option For People At High Risk of Suicide
In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn’t responded to other treatments. Now, the agency is adding patients who are having suicidal thoughts or have recently attempted to harm themselves or take their own lives.
Covey and Luby to receive university recognition for work
Joan Luby will receive Washington University in St. Louis’ 2020 faculty achievement awards, and Douglas F. Covey, the Andrew C. and Barbara B. Taylor Distinguished Professor of Psychiatry at the School of Medicine, will receive the Chancellor’s Award for Innovation and Entrepreneurship.
Schizophrenia, other psychotic disorders focus of new clinic for teens, young adults
Clinic services provided free of charge
On the front lines: Jessica Gold
Psychiatrist discusses mental health during COVID-19 pandemic
$13.7 million to further adolescent brain development study
Grant from National Institute on Drug Abuse to extend landmark study